PODCAST: Etomidate vs. Ketamine for Rapid Sequence Intubation

פוסט זה זמין גם ב: עברית

Dec 23, 2024

Contributor: Ricky Dhaliwal MD

Educational Pearls: 

  • Etomidate was previously the drug of choice for rapid sequence intubation (RSI)

    • However, it carries a risk of adrenal insufficiency as an adverse effect through inhibition of mitochondrial 11-β-hydroxylase activity

  • A recent meta-analysis analyzing etomidate as an induction agent showed the following:

    • 11 randomized-controlled trials with 2704 patients

    • Number needed to harm is 31; i.e. for every 31 patients that receive etomidate for induction, there is one death

    • The probability of any mortality increase was 98.1%

  • Ketamine is preferable due to a better adverse effect profile

    • Laryngeal spasms and bronchorrhea are the most common adverse effects after IV push

    • Beneficial effects on hemodynamics via catecholamine surge, albeit not as pronounced in shock patients

  • 2023 meta-analysis compared ketamine and etomidate for RSI

    • Ketamine’s probability of reducing mortality is cited as 83.2%

    • Overall, induction with ketamine demonstrates a reduced risk of mortality compared with etomidate

  • The dosage of each medication for induction

    • Etomidate: 20 mg based on 0.3 mg/kg for a 70 kg adult

    • Ketamine: 1-2 mg/kg (or 0.5-1 mg/kg in patients with shock)

  • Patients with asthma and/or COPD also benefit from ketamine induction due to putative bronchodilatory properties

References

  1.  Goyal S, Agrawal A. Ketamine in status asthmaticus: A review. Indian J Crit Care Med. 2013;17(3):154-161. doi:10.4103/0972-5229.117048

  2. Koroki T, Kotani Y, Yaguchi T, et al. Ketamine versus etomidate as an induction agent for tracheal intubation in critically ill adults: a Bayesian meta-analysis. Crit Care. 2024;28(1):1-9. doi:10.1186/s13054-024-04831-4

  3. Kotani Y, Piersanti G, Maiucci G, et al. Etomidate as an induction agent for endotracheal intubation in critically ill patients: A meta-analysis of randomized trials. J Crit Care. 2023;77(April 2023):154317. doi:10.1016/j.jcrc.2023.154317

Summarized & Edited by Jorge Chalit, OMS3

Donate: https://emergencymedicalminute.org/donate/

השארת תגובה

חייבים להתחבר כדי להגיב.

גלילה לראש העמוד
Open chat
Scan the code
האיגוד הישראלי לרפואהה דחופה
שלום, קשר ישיר עם ההנהלת האתר איך אפשר לעזור?

Direct contact with the website management
How can we help?
דילוג לתוכן